Navigation path


Enabling techniques for the development of a novel class of protein antibiotics
EC contribution
: € 945.120
: 24 months
Starting date
: 01/08/2005
Funding scheme
: Horizontal Research Activities involving SMEs - Cooperative Research Project
: antibiotics, microbial cell, REPP molecules
Contract/Grant agreement number
: COOP-CT-2005-018191
Project web-site


Antibiotics' resistance to pathogens is a major threat to public health and safety, increasing the risk of mortality, especially in hospital settings. This issue also includes preparedness to deal with bio-terrorism. Currently, the antibiotics market is dominated by small molecule classes, which all face increased drug resistance and require product differentiation. While this remains a primary focus in antibiotics development, new concepts for entirely new classes of substances for the treatment of bacteria, fungi, viruses and protozoa are urgently needed.

[+] Read More